Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol
RANCHO CUCAMONGA, CA / ACCESSWIRE / May 22, 2024 / (NASDAQ:AMPH) today announced that the U.S. Food and Drug Administration ( ...
Research finds few moderate or severe asthma patients prescribed recommended inhaler regimen
Only 14.5% of adult patients with moderate or severe asthma are prescribed the recommended SMART combination inhaler regimen ...
News Medical on MSN11h
Study reveals low adoption of recommended smart inhaler therapy for asthma
Only 14.5 percent of adult patients with moderate or severe asthma are prescribed the recommended SMART combination inhaler ...
healthday on MSN7h
Too Few Asthma Patients Are Using Updated Inhalers
Improved inhalers are now available to help control asthma and treat sudden attacks, but a new study shows that hard ...
Finanznachrichten5h
Amphastar Pharmaceuticals, Inc.: Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol
The FDA determined that Amphastar's albuterol is bioequivalent and therapeutically equivalent to Teva Respiratory LLC's ProAir ® HFA (albuterol sulfate) Inhalation Aerosol. Amphastar's CEO and ...
moneycontrol.com9h
Asthma in children: Avoid triggers that flare-up in summer, manage air quality, plus tips to manage symptoms
This plan should outline daily management and how to handle worsening symptoms. Carry rescue inhaler: Always have a rescue ...